Skip to content

Home
News
Charts
Technical Analysis
Markets
About
Contacts

Home / News / Tag: AstraZeneca

Editorial

#AstraZeneca

All Stocks Crypto Forex Commodities Markets

Stocks
AstraZeneca
Aug 4, 2026

AstraZeneca-Bristol Myers Merger Talks Stir Doubts Over $400 Billion Pharma Deal

Reported merger talks between AstraZeneca and Bristol Myers Squibb have put a potential $400 billion pharmaceutical deal on investors’ radar.…
Stocks
AstraZeneca
Jul 10, 2026

AstraZeneca Shares Drop 5.7% After Wainua Phase 3 Trial Miss

AstraZeneca lost about $24 billion in market value after Wainua failed a pivotal Phase 3 heart trial. Investors are now…

Ultima Markets

XInvest News is owned and operated by IMPULSS LTD, a company registered in the United Kingdom with its office located in 2 Catkin walk, Rugeley, WS15 2NS, UK.

Home

News
Charts
Technical Analysis
Markets

Company

About
Contacts

Legal

Terms and Conditions
Privacy Policy
Cookie Policy
Risk Disclosure
Refund Policy
End User Agreement
Data Deletion Request
AML / KYC Policy

Disclaimer: XInvest is not a broker and does not provide brokerage services. All information is for informational purposes only and does not constitute financial advice. Any trading is at your own discretion and risk.

Risk Warning: Trading leveraged instruments such as derivatives involves a high level of risk to your capital and may not be suitable for all investors. Before engaging in trading, make sure you fully understand these risks in relation to your investment objectives and prior experience. If necessary, seek independent professional advice to support informed decision-making. A solid awareness of the risks associated with margin trading is crucial.

Please take the time to carefully consider all risks and implement proper measures to manage them. For more details, please review our Risk Disclosure Notice.

© XInvest News 2026 · All rights reserved

SSL secured